Electronic Data Capture Systems Market - By Delivery Mode (Web-hosted, Cloud-based, Licensed Enterprise), Clinical Trial Phase (Phase I), End-user (Contract Research Organizations, Pharma & Biotech Companies), Global Forecast, 2023-2032

Electronic Data Capture Systems Market Size

Electronic Data Capture Systems Market size was around USD 1.7 billion in 2022 and is anticipated to grow at a CAGR of over 10.6% between 2023 and 2032. The market has witnessed significant growth over the recent years, driven by the increasing demand for efficient data collection, management, and analysis across the clinical research sector. The growing number of clinical trials in pharmaceutical & biotechnology sectors is also contributing to the EDC systems market growth. For instance, according to World Health Organization International Clinical Trials Registry Platform (ICTRP), the clinical trials globally increased from 57,039 in 2019 to 65,409 in 2021. Thus, EDC becomes a crucial tool or solution for efficiently managing vast amounts of clinical trial data, leading to their widespread adoption, thereby fostering the market growth.
 

Electronic data capture systems (EDC) are designed for the collection of clinical trial data in an electronic format. The majority of data collected in an EDC system is primarily related to managing electronic case report form (eCRF) data. The common function of EDC includes a graphical-user interface component for data entry and unique and secure user permission within the system. Also, these systems are used to replace traditional paper-based data collection methods, allowing organizations to streamline data-related processes and improve data accuracy and efficiency.

COVID-19 Impact

The COVID-19 pandemic has had a significant impact on the global electronic data capture (EDC) systems market, leading to changes in trends, adoption rates, and the usage of EDC systems across various industries. The pandemic accelerated the adoption of digital solutions, including EDC systems, as the standard for data management and clinical research. Organizations recognized the importance of using digital tools to enhance resilience during crises. Furthermore, many research institutions and pharmaceutical companies shifted their focus to COVID-19-related investigations and vaccine trials. Consequently, EDC systems played a crucial role in managing the data generated by these high-priority trial.
 

Electronic Data Capture Systems Market Trends

The increasing research and development (R&D) investments made by pharmaceutical and biopharmaceutical companies are contributing to the growth of the electronic data capture (EDC) market. The firms are recognizing the importance of efficient data management in their research processes. EDC systems offer streamlined and automated data collection, management, and analysis, which can enhance the speed and accuracy of clinical trials and research studies.

As a result, these companies are integrating EDC solutions into their R&D workflows to improve data quality, reduce errors, and expedite the development of new drugs and therapies. Thus, companies seek EDC to optimize their research processes and make data-driven decisions. this trend is expected to continue as the industry places a premium on innovation and efficiency in drug development and clinical research.
 

• Further, the limited uptake of Electronic Data Capture (EDC) systems in developing nations presents a substantial obstacle to the expansion of the global EDC systems market. Numerous challenges are prevalent in these regions, including unreliable internet connectivity, a critical requirement for accessing and effectively utilizing cloud-based EDC systems.
  
   
• Moreover, the inadequate digital infrastructure, characterized by a lack of state-of-the-art computing resources and digital devices, disrupts the smooth implementation and utilization of EDC systems. Additional       ly, healthcare institutions, research facilities, and sponsors of clinical trials in developing countries often grapple with restricted financial means.
   

Consequently, the investment in EDC systems can pose a significant financial burden, particularly when considering the upfront expenses and ongoing subscription fees.
 

Electronic Data Capture Systems Market Analysis

Based on delivery mode, the global EDC systems market is segmented into cloud-based (SAAS) solutions, web-hosted (on-demand) solutions, and licensed enterprise (on-premise) solutions. In the year 2022, cloud-based solutions dominated the market with a substantial share of 52.5%. The factors such as ease of accessibility, data security & compliance, and advanced feature makes cloud-based delivery mode the preferred choice for many organizations when deploying EDC systems.
 

• Also, cloud-based solutions offer the advantage of data accessibility at any given point of time and place. Furthermore, cloud-based server utilizes virtual technology and there are no capital expenses.
   
• The data can be backed up regularly, and companies only have to pay for the resources they use. Such advantage associated with cloud-based is projected to spur the segmental growth.
  
   

Based on clinical trial phase, the global EDC systems market is classified into phase I, phase II, phase III, and phase IV. The phase III segment is expected to reach USD 1.9 billion by the end of 2032. Phase 3 trials involve a significant number of participants and extensive data collection, ultimately creating demand for clinical data management solutions.
 

• EDC reduce the risk of data errors and inaccuracies that can occur with manual data entry. They employ data validation checks, range checks, and other automated features to ensure data accuracy and integrity.
   
• They also assist in the creation and management of essential regulatory documents, which is crucial in Phase 3 trials for regulatory submissions and approvals. Thus, owing to such factors, the phase III segment is expected to dominate the market throughout the forecast period.
   

Based on end-user, the global electronic data capture systems market is classified into contract research organizations (CROs), pharmaceutical & biotechnology companies, medical device companies, hospitals, and other end-users. The contract research organizations segment accounted for USD 654.7 million in 2022.
 

• The highest market share can be attributed to the growing demand for outsourcing clinical trials to various CROs, to minimize the R&D expenses by pharma & biotech companies. CROs are generally hired to accelerate the drug development process.
   
• Therefore, electronic data capture (EDC) are the most prominent eClinical solutions adopted by various CROs to manage growing data volumes. Thus, growing usage of EDC system by CROs companies is expected to boost the market growth.

North America EDC systems market is expected to grow at 9.4% during the analysis period.
 

• The strong foothold of major pharmaceutical and biotechnology companies, medical device companies and research and academic institutions boost the market growth. Also, availability of sophisticated infrastructure further drives the regional growth.
   
• Furthermore, launch of new product by eClinical solution vendors and rising funding from government is augmenting the market. Additionally, increasing clinical research activities in U.S. coupled with growing concern regarding efficient management of large and confidential data volume will increase the adoption of EDC system, thereby supplementing the market growth.
   

Electronic Data Capture Systems Market Share

The industry leaders operating in this market have established themselves through innovation, service quality, and a strong market presence. Medidata Solutions, Inc., Oracle Corporation, and Veena Systems are significant players in this market. These prominent players offer a comprehensive suite of solutions for clinical trial data management. Their cloud-based EDC platform is used widely for collection, management, and analysis of data.
 

Market players operating in the electronic data capture (EDC) systems industry is as mentioned below:

• OpenClinica, LLC
• Medidata Solution, Inc.
• Datatrak International, Inc.
• Eclinical solutions
• Acceliant
• Oracle Corporation
• Omni Comm Systems, Inc.
• DSG, Inc.
• Veeva Systems
• MedNet
   

Electronic Data Capture Systems Industry News:

• In February 2022, Clinixir Company Limited, a leading Thailand-based CRO, opted for Oracle’s pharmacovigilance and clinical research solutions as its eClinical platform. This included the Oracle Clinical One EDC as part of the solutions implemented. This strategy helped the company to boost their revenue growth.
   
• In March 2020, Elsevier, a key information analytics provider, launched Veridata EDC to capture patient data for clinical research. The solution was made available for free to researchers working to develop COVID-19 vaccines and other therapies. This helped company to expand their product offerings and customer base.
   

The global electronic data capture systems market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2018 to 2032 for the following segments:

Click here to Buy Section of this Report

By Delivery Mode

• Cloud-based (SAAS) solutions
• Web-hosted (on-demand) solutions
• Licensed enterprise (on-premise) solutions

By Clinical Trial Phase

• Phase I
• Phase II
• Phase III
• Phase IV

By End-user

• Contract research organizations (CROs)
• Pharmaceutical & biotechnology companies
• Medical device companies
• Hospitals
• Other end-users

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • Rest of Middle East & Africa